Plant ID: NPO5470
Plant Latin Name: Cynoglossum amabile
Taxonomy Genus: Cynoglossum
Taxonomy Family: Boraginaceae
NCBI TaxonomyDB:
354628
Plant-of-the-World-Online:
n.a.
China
ADORA3; ADORA2A; ADORA1; GPR35; | |
RECQL; TDP1; ADK; HPGD; AKR1B1; APEX1; POLB; | |
ACHE; | |
TEK; MET; INSR; NUAK1; EGFR; KDR; SRC; IGF1R; CSNK2A1; | |
CA2; CA1; CA12; CA9; CA7; CA14; | |
KDM4E; | |
PTGS2; | |
STAT1; | |
FUT7; | |
KMT2A; | |
SLC22A6; | |
SMAD3; RAB9A; LMNA; NPC1; THPO; HSPA1A; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | ADK | Adenosine kinase | P55263 | CHEMBL3589 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Enzyme_unclassified | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
Enzyme_unclassified | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | P27695 | CHEMBL5619 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 4.834E-10 | 6.192E-07 | CA1, CA12, CA14, CA2, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.363E-08 | 7.809E-06 | CA1, CA12, CA2, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0038083; peptidyl-tyrosine autophosphorylation | 5.448E-08 | 2.524E-05 | EGFR, IGF1R, INSR, KDR, SRC |
BP | GO:0008283; cell proliferation | GO:0048661; positive regulation of smooth muscle cell proliferation | 6.265E-07 | 1.819E-04 | AKR1B1, EGFR, HPGD, PTGS2, STAT1 |
BP | GO:0009987; cellular process | GO:0001973; adenosine receptor signaling pathway | 7.957E-07 | 2.113E-04 | ADORA1, ADORA2A, ADORA3 |
BP | GO:0009987; cellular process | GO:0051897; positive regulation of protein kinase B signaling | 8.930E-07 | 2.288E-04 | EGFR, INSR, MET, SRC, TEK, THPO |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 1.135E-06 | 2.746E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0050896; response to stimulus | GO:0001666; response to hypoxia | 1.299E-06 | 3.041E-04 | ADORA1, CYP1A1, LMNA, PTGS2, SMAD3, SRC, TEK |
BP | GO:0008152; metabolic process | GO:0045429; positive regulation of nitric oxide biosynthetic process | 1.844E-06 | 4.016E-04 | EGFR, INSR, PTGS2, SMAD3 |
BP | GO:0008283; cell proliferation | GO:0008285; negative regulation of cell proliferation | 1.984E-06 | 4.235E-04 | ADORA1, ADORA2A, ADORA3, CYP1B1, HSPA1A, KMT2A, LMNA, PTGS2, SMAD3, STAT1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.953E-25 | 3.515E-23 | CA12, CA1, CA3, CA5B, CA2, CA5A, CA4, CA7, CA6, CA9, CA14, CA13 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.351E-04 | 5.845E-04 | CYP1A2, CYP1A1, CYP1B1, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 1.752E-04 | 6.857E-04 | ALOX15, CYP2C19, PTGS2, PTGS1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 2.105E-04 | 7.578E-04 | CYP1A2, ALDH1A1, CYP1A1, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.293E-04 | 1.078E-03 | CYP1A2, CYP1A1, CYP1B1, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 8.355E-06 | 5.186E-05 | CYP1A2, ALOX15, CYP3A4, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 3.726E-03 | 7.890E-03 | CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 7.718E-04 | 2.205E-03 | CYP1A2, CYP1A1, CYP1B1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04015 | Rap1 signaling pathway | 1.114E-11 | 6.684E-10 | PDGFRB, SRC, INSR, FLT4, BRAF, EGFR, IGF1R, ADORA2A, KDR, AKT1, MAPK1, TEK, MET |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04151 | PI3K-Akt signaling pathway | 4.135E-09 | 6.203E-08 | PDGFRB, GSK3B, INSR, FLT4, PTK2, EGFR, IGF1R, KDR, AKT1, MAPK1, TEK, TP53, MET |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | RAB9A; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | ADORA3; |
A00-B99: Certain infectious and parasitic diseases | Cryptosporidium infection | A07.2 | EGFR; |
A00-B99: Certain infectious and parasitic diseases | Sepsis | A40, A41 | ADORA1; |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE; |
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE; |
C00-D49: Neoplasms | Glioblastoma multiforme | C71 | EGFR; SRC; |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | INSR; EGFR; CA9; |
C00-D49: Neoplasms | Locally advanced head and neck cancer | C07-C14, C32, C33 | EGFR; |